Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Dose Re-Escalation in Advanced Solid Tumors
NCT00810394Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Dec 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in solid tumor (advanced stage), sponsored by University of California, Davis. Started Dec 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT00810394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810394.